Add to ORKGReporting funding source or conflict of interest in abstracts of randomized controlled trials, no (−1.3; 0.4) (P = 0.39) for abstracts reporting the funding source and CoI versus no funding source and CoI; and −0.6 du Vaure et al. BMC Medicine 2014, 12:6
Over the past three decades, industry sponsored research expanded in the United States. Financial in...
Conflicts of Interest: The authors report no conflicts of interest. The authors alone are responsib...
The subject of conflict of interest (CoI) has long preoccupied bioethicists, particularly as a threa...
ClinicalTrials.gov identifier: NCT01679873International audienceBACKGROUND: Systematic reporting of ...
Background: Systematic reporting of funding sources is recommended in the CONSORT Statement for abst...
Purpose: We sought to determine the prevalence, reliability, and predictors of conflict of interest ...
Context Disclosure of conflicts of interest (COIs) from pharmaceutical industry study funding and au...
Abstract CONTEXT: Disclosure of conflicts of interest (COIs) from pharmaceutical industry study fund...
<div><p>Importance</p><p>It is unclear how medical journals address authors’ financial and non-finan...
We aimed to test any association between authors’ conclusions and self-reported COI or funding sourc...
Transparency in reporting of conflict of interest is an increasingly important aspect of publication...
there was no increase recorded for any one of the three cohorts, or overall, was (x) applying for re...
Over the past three decades, industry sponsored research expanded in the United States. Financial in...
Objectives: Disclosures of funding sources and conflicts of interests (COI) in published peer-review...
Background Accurate conflict of interest (COI) statements are important, as a known COI may invalida...
Over the past three decades, industry sponsored research expanded in the United States. Financial in...
Conflicts of Interest: The authors report no conflicts of interest. The authors alone are responsib...
The subject of conflict of interest (CoI) has long preoccupied bioethicists, particularly as a threa...
ClinicalTrials.gov identifier: NCT01679873International audienceBACKGROUND: Systematic reporting of ...
Background: Systematic reporting of funding sources is recommended in the CONSORT Statement for abst...
Purpose: We sought to determine the prevalence, reliability, and predictors of conflict of interest ...
Context Disclosure of conflicts of interest (COIs) from pharmaceutical industry study funding and au...
Abstract CONTEXT: Disclosure of conflicts of interest (COIs) from pharmaceutical industry study fund...
<div><p>Importance</p><p>It is unclear how medical journals address authors’ financial and non-finan...
We aimed to test any association between authors’ conclusions and self-reported COI or funding sourc...
Transparency in reporting of conflict of interest is an increasingly important aspect of publication...
there was no increase recorded for any one of the three cohorts, or overall, was (x) applying for re...
Over the past three decades, industry sponsored research expanded in the United States. Financial in...
Objectives: Disclosures of funding sources and conflicts of interests (COI) in published peer-review...
Background Accurate conflict of interest (COI) statements are important, as a known COI may invalida...
Over the past three decades, industry sponsored research expanded in the United States. Financial in...
Conflicts of Interest: The authors report no conflicts of interest. The authors alone are responsib...
The subject of conflict of interest (CoI) has long preoccupied bioethicists, particularly as a threa...